Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Minor: CATALINA-2 · TORL-1-23 in Platinum-resistant Ovarian Cancer Enrollment closed, study ongoing
- Minor: A2B395, an Allogeneic Logic-gated CAR T, · Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression Enrollment closed, study ongoing
- Minor: Microdystrophin Gene Transfer Study in Adolescents and · DMD Trial completed
- Minor: Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age Enrollment closed, study ongoing
- Minor: SB17170 Phase 2 Trial in IPF Patients Trial completed
- Minor: CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) Trial completed
- Minor: CDR404 in HLA-A*02:01 · MAGE-A4 Expressing Solid Tumors Enrollment closed, study ongoing
- Minor: CX-5461 · Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation Enrollment closed, study ongoing
- Minor: Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT) Enrollment closed, study ongoing
- Minor: Probiotics · Rheumatoid Arthritis Trial completed
- Minor: Tolerance of a New Formula Based on Hydrolyzed Rice Proteins · Cow's Milk Allergy Trial completed
- Minor: User Experience of BP-CBB Trial completed
- Minor: Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance Trial completed
- Minor: Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer · Different Histologies Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses Trial completed
- Minor: Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care · Previously Treated Multiple Myeloma Primary completion pushed from Oct 31, 2028 to Nov 30, 2028
- Minor: AND017 to Evaluate Efficacy and Safety · Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Primary completion pushed from Dec 1, 2026 to Mar 1, 2027
- Minor: Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients Trial completed
- Minor: TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb) Primary completion pushed from Jun 27, 2026 to Dec 14, 2026
- Minor: Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) Enrollment closed, study ongoing
- Minor: Multiple-Ascending-Dose Study of XTMAB-16 · Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations Primary and study completion pushed from Oct 31, 2026 to Nov 30, 2026
- Minor: Deep Learning for Musculoskeletal Complications in Breast Cancer Trial completed
- Minor: Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies Trial completed
- Minor: Artemis Sleep Countermeasures Trial status changed: Unknown → Completed
- Minor: Live Parent-Child Video Interaction and Cartoon Watching for Emergence Agitation in Children Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates